Parnax Lab Balance Sheet Health
Financial Health criteria checks 3/6
Parnax Lab has a total shareholder equity of ₹674.6M and total debt of ₹590.3M, which brings its debt-to-equity ratio to 87.5%. Its total assets and total liabilities are ₹1.6B and ₹902.7M respectively. Parnax Lab's EBIT is ₹159.9M making its interest coverage ratio 3.3. It has cash and short-term investments of ₹22.4M.
Key information
87.5%
Debt to equity ratio
₹590.33m
Debt
Interest coverage ratio | 3.3x |
Cash | ₹22.41m |
Equity | ₹674.61m |
Total liabilities | ₹902.73m |
Total assets | ₹1.58b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 506128's short term assets (₹656.5M) do not cover its short term liabilities (₹662.8M).
Long Term Liabilities: 506128's short term assets (₹656.5M) exceed its long term liabilities (₹239.9M).
Debt to Equity History and Analysis
Debt Level: 506128's net debt to equity ratio (84.2%) is considered high.
Reducing Debt: 506128's debt to equity ratio has increased from 82.1% to 87.5% over the past 5 years.
Debt Coverage: 506128's debt is well covered by operating cash flow (41.4%).
Interest Coverage: 506128's interest payments on its debt are well covered by EBIT (3.3x coverage).